Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

WALTHAM, Mass., June 3, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX ), a clinical-stage biopharmaceutical company developing an

Related Keywords

Sharon Klahre ,Linkedin ,Syndax Pharmaceuticals Inc ,Twitter ,Nasdaq ,Prnewswire Syndax Pharmaceuticals , ,